help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, S. Y.
Right arrow Articles by Bennett, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, S. Y.
Right arrow Articles by Bennett, L. R.

Journal of Clinical Endocrinology & Metabolism, Vol 46, 691-697, Copyright © 1978 by Endocrine Society

ARTICLES

Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography

SY Wu, IJ Chopra, DH Solomon and LR Bennett

A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients. Serum T4 fell in patients with hperthyroidism, whereas it rose in the other two groups. Sodium ipodate appears to alter peripheral T4 metabolism and, in addition, produces thyroid-inhibiting effects in hyperthyroidism.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
C. S. Bal, A. Kumar, and P. Chandra
Effect of Iopanoic Acid on Radioiodine Therapy of Hyperthyroidism: Long-Term Outcome of a Randomized Controlled Trial
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6536 - 6540.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Panzer, R. Beazley, and L. Braverman
Rapid Preoperative Preparation for Severe Hyperthyroid Graves' Disease
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2142 - 2144.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Bogazzi, L. Bartalena, C. Cosci, S. Brogioni, E. Dell'Unto, L. Grasso, F. Aghini-Lombardi, G. Rossi, A. Pinchera, L. E. Braverman, et al.
Treatment of Type II Amiodarone-Induced Thyrotoxicosis by Either Iopanoic Acid or Glucocorticoids: A Prospective, Randomized Study
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1999 - 2002.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. J. Chopra and K. Baber
Use of Oral Cholecystographic Agents in the Treatment of Amiodarone-Induced Hyperthyroidism
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4707 - 4710.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Braga and D. S. Cooper
Oral Cholecystographic Agents and the Thyroid
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1853 - 1860.
[Abstract] [Full Text]

Home page
 BMJHome page
Grand Rounds--St Bartholomew's Hospital: A lump in the chest
BMJ, December 2, 1995; 311(7018): 1491 - 1494.
[Full Text]

Home page
 CLIN PEDIATRHome page
R. Joshi and H. E. Kulin
Treatment of Neonatal Graves' Disease with Sodium Ipodate: A Case Report
Clinical Pediatrics, March 1, 1993; 32(3): 181 - 184.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1978 by The Endocrine Society